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Abstract.  To study possible functional differences of 
the 18-kD and high molecular weight forms of basic 
fibroblast growth factor (bFGF), we have examined the 
effect of endogenous production of different bFGF 
forms on the phenotype of NIH 3T3 cells. Cells trans- 
fected with cDNAs coding for either 18-kD bFGF (18- 
kD bFGF) or all four molecular forms (18, 22, 22.5, 
24 kD; wild type [WT]  bFGF) exhibit increased 
migration and decreased FGF receptor number com- 
pared to parental cells. However,  migration and FGF 
receptor number of cells transfected with a cDNA 
coding only for high molecular weight bFGF (22, 
22.5,  and 24 kD; HMW bFGF) were similar to that of 
parental cells transfected with vector alone. Cells ex- 
pressing HMW,  18 kD,  or WT bFGF grew to high 
saturation densities in 10%  serum. However,  only 
cells expressing HMW or WT bFGF grew in low se- 
rum. Cell surface or metabolic labeling of the differ- 
ent cell types followed by immunoprecipitation with 
anti-bFGF antibody showed primarily cell surface- 
associated 18-kD bFGE In addition, when cells ex- 
pressing exclusively HMW bFGF were transfected 
with a cDNA coding for 18-kD bFGE migration was 
increased, bFGF receptors were down-regulated, and 
18-kD bFGF was found on the cell surface.  Cells ex- 
pressing 18-kD bFGF transfected with a cDNA encod- 
ing FGF receptor-2 lacking the COOH-terminal do- 
main (dominant negative bFGF receptor) exhibited 
a flat morphology and decreases in migration and 
saturation density.  Cells expressing HMW bFGF 
transfected with the dominant negative bFGF receptor 
continued to grow to a high saturation density, pro- 
liferated in low serum, and exhibited no morphologi- 
cal changes. These results indicate that increased cell 
migration and FGF receptor down-regulation are me- 
diated by the extracellular interaction of 18-kD bFGF 
with its cell surface receptor.  Growth in low serum 
may be stimulated by the intracellular action of HMW 
bFGF through mechanisms independent of the pres- 
ence of a cell surface receptor.  Thus, the different mo- 
lecular forms of bFGF may act through distinct but 
convergent pathways. 
B 
Asic fibroblast growth factor (bFGF) t is the proto- 
type member  of the heparin-binding  growth factor 
family that  currently  includes  eight  other proteins 
(Basilico and Moscatelli,  1992; Miyamoto  et al.,  1993). 
bFGF is a potent mitogen for a variety of cell types, includ- 
ing endothelial cells and fibroblasts, and affects a number of 
additional cellular  functions such as protease  production, 
surface  integrin  levels, and  cell  migration  (Basilico  and 
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1. Abbreviations used in this paper: bFGF, basic fibroblast growth factor; 
BS3,bis (sulfosuccinimidyl) suberate; G418,  geneticin; HMW bFGE high 
molecular weight bFGF; K-fgf, Kaposi's sarcoma FGF; WT, wild type. 
Moscatelli,  1992; Klein et al.,  1993). Many cells produce 
bFGF both in vivo and in vitro. Four different tyrosine kinase 
plasma membrane receptors  for FGF have been described 
and are found on many cell types (Jaye et al., 1992; Basilico 
and Moscatelli, 1992). Basic FGF, like acidic FGF (aFGF), 
does not contain a signal sequence (Abraham et al., 1986) 
and  is  not  released  via  the  classical  secretory  pathway 
(McNeil et al., 1989; Muthukrishan et al.,  1991; Mignatti 
et al.,  1992). Moreover, the mechanism(s)  for release of 
bFGF and aFGF remain(s) unknown.  Different molecular 
forms of bFGF representing alternative translation products 
from a single mRNA have been described (Moscatelli et al, 
1987b;  Sommer,  1987; Florkiewicz  and  Sommer,  1989; 
Prats et ai., 1989). The translation of the smallest molecular 
weight form (18 kD) of  bFGF is initiated at an internal AUG 
codon,  whereas  the  translation  of the  higher  molecular 
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CUG codons 5' to the AUG codon. In vitro most cells pro- 
duce all forms of bFGF. HMW bFGF is preferentially local- 
ized in the nucleus, whereas 18-kD bFGF is found predomi- 
nantly in the cytosol (Quarto et al.,  1991a,b;  Renko et al., 
1991; Bugler et al., 1991; Florkiewicz et al., 1991). The nu- 
clear localization of HMW bFGF is determined by the addi- 
tional amino-terminal sequences not found in 18-kD bFGF 
as proteins containing the unique amino-terminal sequences 
of HMW bFGF fused to B-galactosidase or chloramphenicol 
acetyltransferase accumulate in the nucleus (Quarto et al., 
1991a; Bugler et al., 1991). Fusion of 18-kD bFGF to pyru- 
vate kinase does not direct the chimeric protein to the nu- 
cleus (Quarto, N., unpublished observation). 
The existence of multiple forms of bFGF with different 
subcellular localization raises the question of whether these 
forms of bFGF have different mechanisms of action and 
specialized functions. We have addressed this question by 
creating transfected NIH 3T3 cell lines that express exclu- 
sively 18-kD bFGF, HMW bFGF, or all forms ofbFGF (wild 
type [WT] bFGF) (Quarto et al.,  1989, 1991b). Cells ex- 
pressing increased levels of 18-kD or WT bFGF had growth 
properties of transformed cells, including increased satura- 
tion density and anchorage-independent growth. Cells ex- 
pressing HMW bFGF were of two types; many clones were 
small and had impaired growth as though HMW bFGF ex- 
pression inhibited cell division. These cells contained low 
levels of HMW bFGF and had only one copy of the in- 
tegrated HMW bFGF eDNA. Clones that expressed higher 
levels of HMW bFGF and had multiple copies of integrated 
HMW bFGF cDNA grew rapidly and had the properties of 
transformed cells (Quarto et al.,  1991b). 
To characterize potential functional differences between 
18-kD and HMW bFGF, we extended our analysis of cells 
expressing specific forms of bFGE In this paper, we provide 
evidence for a differential modulation of the cell phenotype 
by endogenous production of either 18-kD or HMW bFGF 
and for different mechanisms of action.  Cells transfected 
with cDNAs for either 18-kD or WT bFGF display enhanced 
migration,  whereas  cells  transfected  with  HMW  bFGF 
cDNA exhibit no changes in migration. Although cells ex- 
pressing HMW or WT bFGF grow in low serum, ceils ex- 
pressing 18-kD bFGF do not. Expression of a eDNA encod- 
ing  a  dominant  negative  bFGF  receptor  reverses  those 
phenotypic properties associated with 18-kD bFGF expres- 
sion but not those associated with HMW bFGE Thus, high 
levels of expression of HMW bFGF may affect cell prolifera- 
tion by a mechanism independent of the presence of a cell 
surface receptor. These data provide evidence for potentially 
different functional mechanisms for HMW and 18-kD bFGF 
action. 
Materials and Methods 
Reagents 
Recombinant human bFGF (18 kD) was a gift from Synergen, Inc. (Boulder, 
CO).  HMW bFGF was purified from guinea pig brains as described by 
Moseatelli et al. (1987). Nal25I (16.93 mCi//zg) was purchased from Amer- 
sham Corp. (Arlington Heights, IL), and 35S-L-cysteine  (1,220 Ci/mmol) 
and 32p-orthophosphate  (8,500-9,120 Ci/mmol) from Dupont Radiochemi- 
cals (Boston, MA). All other reagents were research grade. 
Cells 
NIH 3T3 cells were transfected with the Zip-neo vectors containing either 
a  1.1-kb insert of a eDNA coding all bFGF forms (24, 22.5, 22,  18 kD; 
clones WTFGFcl,  WTFGFc3, WTFGFc7, WTFGFc22),  a eDNA coding 
only for the 24-22-kD  bFGF (clones 365FGFcl,  365FGFc2, 365FGFe9, 
365FGFcl 1, 365FGFcI5), or a eDNA coding only for 18-kD bFGF (clones 
43FGFc8, 43FGF,  c21, 43FGFc31) as described (Quarto et ai., 1989). The 
cells were grown in DME containing 10% FCS plus 500 #g/ml Geneticin 
(G418: GIBCO BRL, Gaithersburg, MD) and were subcultured at a ratio 
of 1:10. 
Secondary transfection of  cells with 18-kD bFGF eDNA: NIH 3T3 cells 
transfected with the Zip-neo vector containing HMW bFGF eDNA were 
subsequently transfected with 18-kD bFGF eDNA inserted in the Zip-neo 
vector  plus the pCEP4  vector  containing a hygromycin resistance  gene 
(kindly provided by Dr. C. Basilico, New York University Medical Center, 
New York, NY) at a ratio of 8:1. Hygromycin-resistant clones were selected 
in DME containing 10% FCS, 200 t~g/ml of hygromycin B (Calbiochem- 
Behring Corp., La Jolla, CA) and 250 #g/ml of G418. Secondary transfec- 
tants were identified by Western blotting of  ceil extracts with anti-bFGF an- 
tibodies (clones: 365/43 NC1; 365/43 NC2; 365/43 NCI2; 365/43 NC33). 
Transfection with a dominant negative bFGF receptor eDNA: NIH 3T3 
cells transfected with the Zip-neo vector containing either HMW, 18 kD, 
or WT bFGF cDNAs were cotransfected with pRK5 containing a 1.3-kb in- 
sert of a human bek (FGF receptor 2) eDNA that lacks the COOH-terminai 
tyrosine kinase domain (dominant negative bFGF receptor; kindly provided 
by Dr.  J.  Schlessinger, N.Y.U. Medical Center)  and the pCEP4  vector. 
Hygromycin-resistant clones were selected in DME containing 10% FCS, 
200 ttg/ml of hygromycin, and 250/~g/ml of G418. Resistant clones were 
tested for high affinity bFGF receptors according to Moscetelli (1987) and 
by cross-linking to cell surface receptors  with  125I-bFGF. HMW bFGF 
clones: 365DNc2, 365DNc4, 365DNc5, 365DNc6, 365DNc7, 365DNc12, 
365DNc14, 365DNe24,  365DNc28, 365DNc32,  365DNc38, 365DNc39, 
365DNc42,  365DNc43, 365DNc46, 365DNc47, 365DNc51, 365DNc63, 
365DNc71, 365DNc80; control clones transfected with the cDNA encoding 
the hygromycin-resistant  gene alone: 365FGFI-Ic3, 365FGFHc5, 365FGFI-Ic8; 
18-kD bFGF clones: 43DNc8, 43DNc10, 43DNcI1, 43DNc30, 43DNc31, 
43DNc33, 43DNc38, 43DNc62, 43DNc72, 43DNc73; control clones trans- 
fected  with  the eDNA  encoding  the  hygromycin-resistant gene  alone: 
43FGFHc3,  43FGFHe8,  43FGFHc10;.  WT  bFGF  clones:  WTDNcl, 
WTDNc2, WTDNc3, WTDNc4, WTDNcT; control clones transfected with 
the eDNA  encoding the hygromycin-resistant gene alone:  WTFGFHc3, 
WTFGFHc5,  WTFGFHcl0. 
These clones were analyzed with comparable results in the experiments 
shown in the figures and were obtained from at least tvza independent trans- 
fections. 
Cell Migration Assay 
Cell  migration  was assayed by the phagukinetic track  assay (Albrecht- 
Buehler,  1977) as modified by Mignatti et al.  (1991, 1992). Briefly, 20 
cells/well were seeded on coverslips coated with 1% BSA (Sigma Chem. 
Co., St. Louis, MO) and colloidal gold and incubated at 37°C in 24-well 
plates. 
The medium was replaced with fresh medium after 2 h. After overnight 
incubation at 37°C, the cells were fixed with 3.7% formaldehyde and track 
areas were measured with an image analyzer (model 982; Artek Systems 
Corp., Farmingdale, NY). The area units obtained with the image analyzer 
(pixels) were converted into/~m  2 by interpolation with a calibration curve 
obtained by measuring the size of  different squares ofa hemocytometer. The 
data were plotted as a probability plot using Kaleidograph software run on 
an Apple Macintosh IIsi computer. 
Cell Proliferation Assay 
20,000 cells were seeded in 3.5 em culture dishes. After overnight incuba- 
tion at 37°C, the cells were refed with DME containing either 10% or 1% 
FCS. The cells were counted with a Coulter counter (Coulter Electronics, 
Hiaieah,  FL) every day for 8 to 10 days. 
Growth in Soft Agar 
10,000-100,000 cells were seeded in 6 cm dishes in DME containing 10% 
FCS plus 0.3% agar (2 ml) on a 0.6% (3 ml) agar underlay. The cells were 
refed twice a week with DME containing 10% FCS and 0.3% (1.5 ml) agar. 
Colonies were counted after a 3-wk incubation at 37°C. 
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Cells were labeled with 35S-L-cysteine (250 #Ci/ml) for 30 rain in cys- 
teine-free minimal Eagle's medium (MEM) and chased with MEM contain- 
ing 7%  FCS and 250/~m/ml of L-o/steine. At the indicated times,  the 
medium was collected, and the cells were washed twice with 20 mM Tris- 
HCI, 2 M NaCI, pH 4.0, to remove cell surface-associated bFGE The cells 
were harvested with 20 mM Tris-HCl, pH 7.4, containing 2 M NaCI, 3 mM 
EDTA, 20 U/ml of Trasylol (Sigma Chem. Co.), I mM DTT (Sigma Chem. 
Co.), and 0.5 #g/mi of leupeptin (Sigma Chem. Co.) (buffer  1), sonicated 
and kept on ice for 30 rain. The NaCI concentration was adjusted to 0.5 M 
with lysis buffer (20 mM Tfis-HCI,  pH 7.4,  3  mM EDTA,  0.3%  SDS, 
1% Triton X-100, 1 mM DTT, 0.5 #g/ml leupeptin, 20 U/ml of Trasylol, 
and 0.1% BSA). 
Conditioned media, 2 M NaCI cell surface washes, and cell extracts were 
precleared with 100/d of  protein A-Sepharose (Pharmacia Fine Chemicals, 
Piscataway, NJ) and immunoprecipitated with anti-bFGF antiserum (1/200 
vol/vol).  In some experiments the NaCI concentration of the samples was 
adjusted to 0.5 M NaCI with NaCl-free buffer 1, and the samples were in- 
cubated with  150 #1 of heparin-Sepharose beads for 2  h  at 37°C.  The 
heparin-Sepbarose  beads were washed twice with the same buffer and eluted 
with buffer 1 containing 2 M NaC1. The NaCI concentration was adjusted 
to below 0.5 M and immunoprecipitation  was performed as indicated above. 
Sample volumes were normalized to protein concentration. After overnight 
incubation at 4°C, the beads were washed five times with lysis buffer, and 
the entire sample loaded in reducing sample buffer on 10 or 15 % SDS-poly- 
acrylamide gels. After electrophoresis the gels were dried and analyzed by 
PbospborImager (Molecular Dynamics, Sunnyvale, CA) or by autoradiog- 
raphy using XAR-5  film (Eastman Kodak,  Rochester,  NY). 
nJI-bFGF  Binding Experiments 
Binding experiments for nigh or low affinity bFGF receptors were  per- 
formed as described (Moscatelli, 1987). Cells in 35 or 60 nun dishes were 
incubated in duplicate with the indicated  concentrations of 125I-bFGF at 
4°C with or without recombinant bFGE After a 2-h incubation, the cells 
were washed  three times with ice-cold  PBS and binding to high or low 
affinity receptors analyzed as described (Moscatelli,  1987).  Cross-linking 
of 125I-bFGF receptors was performed as follows: After a 2-h incubation 
with t25I-bFGE cells were washed three times with ice-cold  PBS and in- 
cubated for 20 rain at room temperature with 1 mM bis (sulfosuccinimidyl) 
suberate (BS3; Pierce Chem. Co., Rockford, 1L). At the end of the incuba- 
tion the cells were washed twice with PBS, iysed with sample buffer (0.01% 
Bromphenol blue, 1% SDS, and 20% glycerol in 50 mM Tris, pH 6.8). The 
proteins were separated on either 6 or 8 % SDS-polyacrylamide gels under 
reducing conditions, and the iodinated proteins visualized by autoradiogra- 
phy. The samples were analyzed  in duplicate. 
Tyrosine Phosphorylation 
Cells incubated for 10 min with or without 100 ng/ml of bFGF were labeled 
for 3 h with 32p-orthophosphate (125 #Ci/60 mm dish) in labeling medium 
(25 mM Hepes,  125 mM NaCI,  4.8 mM KCI, 2.6 raM CaCi2,  1.2 mM 
MgSO4, 5.6 mM glucose,  and 0.1% BSA, pH 7.4). The cells were washed 
once with cold Ca  2+-, Mg2+-free PBS and extracted in lysis buffer (10 mM 
Tris-HCl, 50 mM NaF, 50 mM NaCI,  30 mM Na pymphosphate, 5 mM 
EDTA,  100 #M Na orthovanadate,  I% Triton X-100, and 1 mM PMSF, 
pn 7.4). 
Phosphorylated  proteins  were  immunoprecipitated  with  anti-phos- 
photyrosine antibodies coupled to Agarose (R & D Systems, Minneapolis, 
MN) or afffinity-purified anti-phospbotyrosine antibodies bound to protein 
A-Sepharose (kindly  donated by Dr.  W. Burgess,  Holland Laboratories, 
American Red  Cross,  Rockville,  MD).  After overnight incubation, the 
beads were washed  six times in wash buffer,  placed in reducing sample 
buffer, and electrophoresed  in 8 or 10% SDS polyacrylamide  gels. The gels 
were dried and exposed to XAR-5 film. 
Cell Surface Labeling and Immunoprecipitation 
Subconiluent NIH 3T3 cells in 15 cm dishes (Falcon Plastics, Cochranville, 
PA) were washed with PBS and detached with 5 mM EDTA. The suspended 
cells were washed three times with PBS, and surface proteins were labeled 
with lactoperoxidase  (158/~g/mi;  Sigma Chem. Co.), 0.0038%  He(h, and 
Na 12sI (1 mCi/ml). The cells were washed three times with DME contain- 
ing 0.02%  NaN3 and solubilizad  in 25 mM Tris-HC1,  pH 7.4,  150 mM 
NaCl,  1 mM CaC12,  1 mM MgCl2,  and 0.5%  Triton X-100 containing 
leupeptin (10/zg/ml), pepstatin A (4 #g/ml), and aprotinin (50 #g/ml). The 
m25I-labeled cell lysates  were clarified  in an Eppendorf microfuge  for 30 
min and preabsorbed with normal rabbit IgG and protein A-Sepharose. To 
adjust for changes in cell umber due to bFGF, the radiolabeled cell extracts 
were  normalized to TCA precipitable radioactivity.  Antibody to bFGF 
(1/150 dilution) was added to aliquots of the cell lysates and rotated for 1 h 
at 4°C.  Protein A-Sephamse beads were added to each sample,  and the 
samples rotated for 1 h at 4°C. The beads were washed five times with 0.5 % 
sodium deoxycholate, 0.1% SDS, 1% Triton X-100, 150 mM NaC1, and 50 
mM Tris HCI,  pH 7.4, boiled for 5 min in reducing  SDS-PAGE sample 
buffer, and electrophoresed  in 12% SDS-polyacrylamide gels. Dried gels 
were exposed  to XAR-5  film or analyzed by Phosphorlmager scanning. 
Results 
Migration Is Stimulated in NIH 3T3 Cells 
Expressing 18-kD bFGF but not in Cells Expressing 
HMW bFGF 
Because endogenous production of bFGF affects cell migra- 
tion (Mignatti et al.,  1991), we examined the migration of 
NIH 3T3 cells transfected with different species of bFGF. 
For these studies, we used the phagokinetic gold track assay 
as NIH 3T3 cells migrate in an FGF-dependent manner in 
this assay (Mignatti et al., 1991, 1992).  As shown in Fig. 1 
a, NIH 3T3 cells transfected with a eDNA encoding 18-kD 
bFGF have an increased capacity to migrate when compared 
with control cells transfected with vector alone. This result 
is consistent with data obtained previously with cells overex- 
pressing WT bFGF (Mignatti et al.,  1991). The cells pro- 
duce approximately 84 ng 18-kD bFGF or 190 ng WT bFGF 
per mg of total cell protein as determined by ELISA (Brun- 
ner et al., 1993). In contrast, NIH 3T3 cells from two clones 
transfected with the HMW bFGF eDNA migrated to the 
same extent as control cells. These cells produce ~85 ng of 
HMW bFGF per mg of cell protein. 
The migration of WT bFGF expressing cells has been 
shown to  depend upon the extracellular concentration of 
bFGF  (Mignatti et al.,  1991). Therefore, we investigated 
whether addition of exogenous recombinant bFGF also in- 
creased  the migration of NIH  3T3  cells transfected with 
HMW bFGF eDNA (Fig. 1 b). Addition of recombinant 18- 
kD bFGF increased the migration of cells transfected with 
the HMW bFGF eDNA (clone 365FGFc2) as well as that of 
control cells (Fig. 1 b). Thus, the lack of migration of cells 
expressing high amounts of HMW bFGF is not the result of 
the cells being refractory to the stimulation of exogenous 
bFGF. In contrast, the migration of cells transfected with the 
eDNA encoding 18-kD bFGF was not enhanced by exposure 
to exogenous bFGF (Fig.  1 c), probably because the migra- 
tion of these cells is maximal under normal conditions (Mig- 
natti et al.,  1991, 1992). 
HMW bFGF purified from guinea pig brain stimulated the 
migration of both control cells and cells expressing only 
HMW bFGF as efficiently as recombinant 18-kD bFGF (Ta- 
ble 1). Therefore, the low level of  migration in NIH 3T3 cells 
expressing only HMW bFGF does not result from an inabil- 
ity to respond to extracellular bFGF or from HMW bFGF 
lacking migration-inducing activity on NIH 3T3 cells. 
Low Serum Is Permissive  for The Growth 
of Cells Expressing  HMW bFGF  but not for 
Cells Expressing 18-kD bFGF 
In the presence of 10% serum, cells expressing high levels 
of 18-kD, HMW, or WT bFGF grow to high saturation den- 
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Figure L  Phagokinetic track areas formed by NIH 3T3 cells trans- 
fected with different bFGF cDNAs or with the vector alone. Cells 
were seeded onto colloidal gold-coated coverslips at a density of 
20 cells/coverslip. Following 16-h  incubation at 37°C,  measure- 
ment of the phagokinetic track areas and elaboration of the results 
were performed as described in Materials and Methods. Each point 
shows the probability of finding a phagokinetic track with an area 
equal to or lower than the value indicated on the abscissa. The data 
were plotted using a probability scale on the ordinate. (a) Migration 
of  ceils  expressing  HMW  bFGE  (&)  Cells  expressing  HMW 
bFGF, clone 365 FGFc2, mean track area  -t- SEM: 481.1  5:28.8 
/xm  2, (X) clone 365FGFcl: 609.4  5:64 #m2; (e) cells expressing 
18-kD bFGF, clone 43FGFc31:1481.9  +  90.1  /xm2; (*) control 
cells, Zipneo: 716.2  5:45.8/xm  2. (b) Migration of cells expressing 
HMW bFGF in the presence of exogenous bFGE  The migration 
of cells expressing HMW bFGF (clone 365FGFc2) or control cells 
(Zipneo) was measured either in the absence (&, 365FGFc2;  *, 
Zipneo) or the presence (A, 365FGFc2;  Zipneo) of 20 ng/ml of 
bFGE In the presence of bFGF, the mean track area of control cells 
was 1339.8  5:128.7/xm  2 (unstimulated 679.6  5:61.8 #m  2) and that 
of 365FGFc2 cells was  1153.6  5:92 #m  2 (unstimulated 505.1  + 
35.5  /xm2). (c)  Migration of ceils expressing  18-kD bFGF in the 
Table L  Effect  of Guinea  Pig HMW bFGF on the 
Migration  of Either Cells Expressing  HMW bFGF or 
Control  Cells 
Addition  Control cells  HMW bFGF expressing cells 
Mean track area  in lun  2  +  SEM 
None  721  +  64  460  +  52.6 
HMW bFGF  1236.9  +  70.9  1005  +  80.9 
(20 ng/ml) 
Cells were plated on colloidal gold-coated coverslips and their migration was 
measured as described in Materials and Methods. The track areas (~m  2) of at 
least 15 cells were measured for each sample. 
sities compared to control cells transfected only with vector 
(Quarto et al.,  1989). However, in the presence of 1% FCS 
(Fig. 2), the growth of cells expressing HMW or WT bFGF 
was much higher than that of cells expressing only 18-kD 
bFGE The growth of cells expressing 18-kD bFGF in  1% 
FCS was similar to that of the control cells transfected with 
vector alone. Similar results were obtained with two addi- 
tional  clones  of each  type  isolated  from an  independent 
transfection (data not shown). 
FG  F Receptors Are Down-modulated 
in Cells Expressing 18-kD bFGF but not in Cells 
Expressing HMW bFGF 
To investigate  whether FGF receptors are modulated differ- 
ently  in NIH 3T3 cells expressing the different species of 
bFGF,  the  binding  of  '25I-bFGF to  cells  was  examined. 
When the cells were incubated  with saturating  concentra- 
tions of '25I-bFGF, bFGF binding to high affinity  receptors 
was decreased in cells expressing 18-kD bFGF compared to 
control  cells  (Fig.  3  a).  In  contrast,  the  binding  to high 
affinity receptors in cells transfected  with HMW bFGF was 
only slightly decreased. These differences were maintained 
for at least six days after plating.  Cells expressing all forms 
of bFGF  also  displayed  strongly  reduced  binding  of ~2sI- 
bFGF  to  high  affinity  receptors  as  described  previously 
(MoscateUi and Quarto,  1989).  These results  suggest that 
high affinity  receptors for bFGF were down modulated in 
cells expressing  18-kD bFGF but not in cells expressing 
HMW bFGE 
To  substantiate  this  hypothesis,  bFGF  receptors  were 
characterized  by chemical cross-linking to  '2SI-bFGE Au- 
toradiograms  of the  cross-linked  cell  extracts  after  SDS- 
PAGE showed a  significant decrease in the amount of the 
~130-150-kD band corresponding to the bFGF receptor in 
cells expressing 18-kD bFGF (Fig.  3 b).  However, in cells 
expressing  only  HMW  bFGE  the  intensity  of the  bFGF 
receptor band  was  only  slightly  diminished  compared  to 
control  cells.  Binding  of  ~25I-bFGF was  competed by  in- 
presence of exogenous bFGF or anti-bFGF antibodies. The migra- 
tion of cells expressing only 18-kD bFGF (clone 43FGFc31) was 
measured either in the presence of (o; 1717.1 +  205.0 t~m  2) or ab- 
sence (¢; 1802.3  -t- 198.4 #m  2) of 20 ng/ml bFGF with (®; mean 
track  area  -t-  SEM:  837.8  +  60.8  /~m  2)  or without  (e)  afffinity- 
purified anti-bFGF antibodies (20 ~tg/ml).  Control ceils (*, Zip- 
neo, 679.6  -l- 61.8/~m2). 
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Figure 2. Growth of cells expressing HMW, 18 kD, or WT bFGF 
in 1% serum.  Cell growth was monitored over the indicated time 
intervals in the presence of 1% FCS as described in Materials and 
Methods.  Cells  expressing  HMW (o,  clone  365FGFc2),  18-kD 
(A, clone 43FGFc31), or WT bFGF (I, clone WTFGFc3).  Con- 
trol (o, Zipneo).  This experiment was repeated three times with 
similar results. Each point represents the mean + SEM of  duplicate 
samples. 
cubating the cells with a  100-200-fold excess of unlabeled 
bFGF before cross-linking. 
FGF receptor activation by exogenous bFGF was also in- 
vestigated by immunoprecipitating ~2P-orthophosphate-labeled 
cell  extracts  with  antiphosphotyrosine  antibodies.  These 
results revealed that exogenous bFGF stimulated the phos- 
phorylation of several proteins,  including proteins at  130- 
150 and 90 kD, in both control and in cells expressing HMW 
bFGF, but not in cells expressing 18-kD bFGF (manuscript 
in preparation). In ceils expressing 18-kD bFGF, however, 
enhanced phosphorylation of the 130-150-kD band was ob- 
served without the addition of bFGF. On some occasions ad- 
dition of recombinant bFGF to these ceils decreased the level 
of protein phosphorylation. The reasons for this decrease are 
not understood. 
Transfection of Cells Expressing Only HMW 
bFGF with 18-kD bFGF cDNA Results in Increased 
Migration and FGF Receptor Down-regulation 
To test the hypothesis that increased migration and receptor 
down-regulation were mediated by  18-kD bFGF,  cells ex- 
pressing only HMW bFGF were transfected with a  eDNA 
encoding 18-kD bFGF and a eDNA containing a hygromycin 
resistance  gene.  The  resultant  cells  that  expressed  both 
HMW and  18-kD bFGF were more refractile and spindle 
shaped than the  parental  cells that expressed only HMW 
bFGF (Fig. 4). These cells that expressed all forms of bFGF 
also resembled cells treated with recombinant 18-kD bFGF 
(data not shown). 
The doubly transfected cells displayed an increase in mi- 
gration compared to control cells (Fig. 5). In addition, when 
cells expressing  HMW bFGF transfected with the  18-kD 
bFGF eDNA were assayed for bFGF binding to high affinity 
receptors, a decrease in receptor number was observed (data 
not shown). However, the ability of cells expressing HMW 
bFGF to grow in the presence of 1%  FCS was essentially 
unaffected by transfection with the  18-kD eDNA (Fig.  6). 
Cell Migration and Receptor Down-regulation 
Correlate V~th 18-kD bFGF Release 
The previous results indicating differences between cells ex- 
pressing HMW or 18-kD bFGF are most easily explained by 
postulating the release of 18-kD bFGF but not HMW bFGE 
Figure 3. High affinity binding and cross-linking of 125I-bFGF to NIH 3T3 cells expressing HMW or 18-kD bFGE (a) Binding of t25I- 
bFGF to cells. Binding experiments were performed as described in Materials and Methods. Black  bars, control cells (Zipneo); open bars, 
cells expressing 18-kD bFGF (clone 43 FGFc31); grey bars, cells expressing HMW bFGF (clone 365FGFc2).  The values represent the 
mean  +  SEM  of duplicate  samples.  (b) Cross-linking  of ~25I-bFGF to cells.  Control  cells  (Zipneo),  cells  expressing  18-kD (clone 
43FGFc31), or HMW bFGF (clone 365FGFc2) were incubated with ~25I-bFGF  either in the absence (-) or presence (+) of unlabeled 
bFGE Bound ~25I-bFGF  was cross-linked to cells as described  in Materials  and Methods and the samples analyzed by SDS-PAGE and 
autoradiography.  The arrowhead indicates the position of the FGF receptor. 
Bikfalvi et al. bFGF  Effect on Cellular Phenotype  237 Figure 4. Morphological changes induced in cells expressing HMW bFGF by supertransfection with 18-kD bFGF cDNA. Cells were trans- 
fected as described in Materials and Methods; transfected cell clones were identified by Western blotting with anti-bFGF antibodies. (a) 
Cells expressing HMW bFGF (clone 365FGFHc3). (b) Cells supertransfected with 18-kD bFGF eDNA (clone 365/43NC33). The corre- 
sponding Western blots (WB) of cell extracts are shown in the right upper corner of each figure. Bar, 100/~m. 
However,  bFGF  has  no  secretion  signal  and  is  released 
inefficiently. In order to establish whether the phenotypic 
changes observed with cells expressing 18-kD bFGF were 
due to extracellular release of the growth factor, we tested 
the  effects of protein  G-purified or affinity-purified anti- 
bFGF IgG on migration and FGF receptor levels in those 
cells. In the presence of  anti-bFGF antibodies, the migration 
of  cells transfected with the 18-kD bFGF cDNA was reduced 
to control levels (Fig. 1 c). Previous experiments have shown 
that these antibodies also reduce the migration of cells ex- 
pressing WT forms ofbFGF (Mignatti et al., 1991). Because 
in this assay cell migration is mediated by the bFGF pro- 
duced by the cells (Mignatti et al., 1991), this result demon- 
strated that 18-kD bFGF must be released in order to stimu- 
late  their  migration.  Treatment of the  cells  with  protein 
G-purified or affinity-purified antibodies also increased the 
cell surface binding of bFGF to high affinity receptors (Fig. 
7). This increase was 3.5-fold for cells expressing only 18- 
kD bFGF and sixfold for cells expressing WT bFGE Similar 
results were obtained when receptor levels were measured 
by cross-linking of '25I-bFGF to cells treated with affinity- 
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Figure 5.  Migration of cells expressing HMW bFGF transfected 
with 18-kD bFGF eDNA. Migration assays were carried out as de- 
scribed in Materials and Methods. Cells expressing HMW bFGF 
(clone 365FGFHc3: Mean Track Area +  SEM = 416 +  25 #m  2 
(A); Cells expressing HMW bFGF transfected with 18-kD bFGF 
eDNA (clone 365/43nc33:1044.1  4- 65.5/zm  2) (v). 
purified antibody to bFGF (data not shown). Thus, down- 
modulation of bFGF receptors also may be due, at least in 
part, to the release of 18-kD bFGF and its interaction with 
the cell surface receptor. 
We next assayed for cell surface-associated bFGF by im- 
munoprecipitation  of extracts  from  surface-labeled  cells 
with anti-bFGF antibodies. As shown in Fig. 8, bFGF was 
only found on the surface of cells expressing either 18-kD 
bFGF or all forms of bFGE Cells that expressed exclusively 
HMW bFGF exhibited only trace amounts of HMW bFGF 
and a degradation product migrating slightly slower than 18- 
kD  bFGE  However,  the  total  amount  of  HMW  bFGF 
released was less than found in 18-kD bFGF producing cells. 
Immunoprecipitation of surface-labeled extracts of cells ex- 
pressing  HMW bFGF  that  were subsequently transfected 
with the 18-kD bFGF eDNA also revealed a band of 18-kD 
bFGF (Fig.  8). 
These results were confirmed by the analysis of the distri- 
bution of metabolically labeled bFGE Cell extracts, culture 
media, and 2 M NaC1 cell surface washes were immunopre- 
cipitated  with  a  specific anti-bFGF  serum,  and  the  im- 
munoprecipitates were subjected to SDS-PAGE. bFGF was 
detected in the immunoprecipitates from the cell extracts of 
all transfected clones but not from the conditioned media 
(data not shown). In addition,  18-kD bFGF was present in 
the 2 M NaCI cell surface wash from cells transfected with 
18-kD bFGF eDNA (clone 43FGFc31) or WT bFGF eDNA 
(clone  WT  FGFc3).  No  bFGF  (either  18-kD  or  HMW 
bFGF) could be immunoprecipitated from the cell surface 
wash or from the medium of cells transfected with HMW 
bFGF  eDNA  (clone  365FGFc2)  (data  not  shown).  The 
difference in sensitivity between iodination (Fig. 8) and the 
metabolic labeling probably accounts for the inability to de- 
tect any surface-bound HMW bFGF by the latter approach. 
Thus, the changes in migration and bFGF receptor level of 
NIH 3T3 cells expressing different species of  bFGF correlate 
with the release of 18-kD but not HMW bFGF on the cell 
surface. 
Expression of  a Dominant Negative bFGF Receptor 
Reverts the Phenotype of Cells Expressing 18-kD bFGF 
but not That of Cells Expressing HMW bFGF 
To determine whether the interaction of bFGF with its high 
affinity receptor was responsible for the phenotypic changes 
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Figure 6. Proliferation of cells expressing HMW bFGF transfected 
with 18-kD bFGF eDNA• The experiment was carried out as de- 
scribed  in Materials  and Methods.  (a) Growth in  10%  FCS;  (b) 
growth in 1% FCS. Cells expressing HMW bFGF (zx, clone 365 
FGF He3); 365FGFHc3 cells transfected with 18-kD bFGF eDNA 
(A, 365/43nc33), or Zipneo (O). The data represent mean +  SEM 
of duplicate  samples. 
exhibited by cells expressing the different forms of bFGE 
NIH 3T3 cells expressing 18-kD, HMW, or WT bFGF were 
transfected with a eDNA encoding a dominant negative type 
2 FGF receptor. Ueno et al. (1992) have shown that expres- 
sion of a dominant negative receptor of this type inhibits sig- 
naling initiated by all FGF receptor types. Stable transfec- 
tants were isolated and were characterized by binding and 
cross-linking  of  ~25I-bFGF to  cell  surface  receptors.  By 
quantitating the amount of ~25I-bFGF bound to cells, as il- 
luslrated in Fig. 3 a, clones were obtained that bound up to 
17 times more bFGF than did the control Zipneo cells (data 
not  shown).  The presence of the  dominant  negative FGF 
receptor was verified by the demonstration of a major band 
of 90 kD and multimeric complexes of 150-200 kD seen after 
Figure 7. Effect of anti-bFGF antibodies on FGF receptor expres- 
sion. Cells expressing 18-kD or WT bFGF were incubated for 24 h 
with or without 100/zg/ml of protein-G-purified  anti-bFGF anti- 
body (AB) or 100 ~g/ml of non-immune antibody. Binding of ~2sI- 
FGF to its receptor was determined as described in Materials and 
Methods. Open bars, non-immune antibody;filled bars, anti-bFGF 
antibody. 
incubation  of the  cells  with  125I-bFGF and  cross-linking 
with BS3 (Fig. 9,  insets). 
Cells expressing 18-kD or WT bFGF and high levels of 
the  dominant  negative  receptor  eDNA  lost  their  spindle 
shape and displayed a flat morphology (Fig. 9, compare im- 
ages a to d and c to  f). In contrast, cells co-expressing HMW 
bFGF and the dominant negative receptor exhibited no mor- 
phological change despite their high expression of the domi- 
nant negative bFGF receptor (Fig. 9, compare image b to e). 
Cells expressing 18-kD or WT bFGF plus the dominant 
negative bFGF receptor were also characterized for migra- 
tion. These cells showed decreased motility in phagokinetic 
assays (Fig.  10) compared to cells expressing only 18 kD or 
WT bFGF. Thus, expression of the dominant negative recep- 
tor prevented the signaling necessary for the stimulation of 
cell migration induced by 18-kD bFGE 
Figure  8.  12~I-labeling  of cell 
surface-associated bFGE ~25I- 
labeling of cells, immunopre- 
cipitation,  SDS-PAGE, and 
Phosphorlmager analysis were 
carried  out  as  described  in 
Materials and Methods. Cells 
expressing 18-kD bFGF (clone 
43FGFHc8),  HMW  bFGF 
(clone  365FGFHc3),  WT 
bFGF (clone WT FGFc3), or 
cells expressing HMW bFGF 
transfected with a eDNA en- 
coding  18-kD bFGF (HMW/ 
18-kD  bFGF;  clone  365/ 
43NC33) were immunoprecipi- 
tated  with  anti-bFGF  anti- 
bodies.  Control,  ceils  trans- 
fected  with  the  vector alone 
(Zipneo). 
Bikfalvi et al. bFGF  Effect on Cellular Phenotype  239 Figure 9. Morphological changes induced by transfection with a dominant negative FGF receptor cDNA.  Cells expressing 18-kD bFGF, 
HMW bFGF, or WT bFGF were transfected with a dominant negative FGF receptor type 2 cDNA.  Calls expressing high levels of the 
dominant negative receptor were isolated as described in Materials and Methods. Cells transfected with the cDNA encoding the dominant 
negative receptor (clones d, 43 DNcl 1; e, 365DNc28;f, WTDNc2). Control cells (a, 43FGFHc8; b, 365FGFHc3; c, WTFGFHc31). Auto- 
radiograms of extracts from cells cross-linked (CL) with ~2~I-bFGF  and subjected to SDS-PAGE as described  in Materials and Methods 
are shown in the right upper corner of each figure. Open arrow, cross-linked ~25I-bFGF  to endogenous receptors in cells expressing HMW 
bFGF; large black arrow, major cross-linked band of 90 kD in cells expressing the dominant negative FGF receptor; small black arrows, 
multimeric complexes of 150-200 kD in cells expressing the dominant negative bFGF receptor.  Bar, 100 #m. 
HMW bFGF Modulates Cell Growth by a Mechanism 
Independent of Its Cell Surface Receptor 
In the presence of 10%  FCS cells expressing the dominant 
negative FGF receptor and 18-kD bFGF grew to saturation 
densities that were lower than those of cells that did not ex- 
press the dominant negative receptor (Fig. 11 a). These satu- 
ration  densities  were  comparable to  that  of control  cells 
transfected with the vector alone. In contrast, cells that ex- 
pressed both HMW bFGF and the dominant negative FGF 
receptor grew to a saturation density comparable to that of 
cells that  did  not  express the  dominant  negative receptor 
(Fig.  11  b). 
In the presence of 1% FCS, cells transfected with 18-kD 
bFGF and the dominant negative FGF receptor, as well as 
cells transfected with the vector alone, grew slowly (Fig.  11 
c). In contrast, cells expressing HMW bFGF and the domi- 
nant negative FGF receptor grew rapidly (Fig. 11 d, and data 
not shown). As shown above, transfection of cells expressing 
HMW bFGF with  18-kD bFGF cDNA did not affect their 
growth rate or saturation density in the presence of either 10 
or  1%  FCS (Fig.  6). 
In addition, expression of the dominant negative receptor 
significantly inhibited the soft agar growth only of cells ex- 
pressing  exclusively  18-kD  bFGF (Table II).  The cloning 
efficiency of cells expressing only 18-kD bFGF was reduced 
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Figure 10. Migration of cells expressing  18-kD bFGF or WT bFGF 
plus the dominant negative FGF receptor. Cells were isolated as de- 
scribed in Materials  and Methods and their migration measured as 
described in the legend to Fig. 1. (a) Track areas of cells expressing 
18-kD bFGF and the dominant negative FGF receptor ([],  clone 
43DNcll: mean track area +  SEM =  494.2  +  35.0 #m2; and o, 
clone 43DNc38:582.4 -t- 69.8 #m2), and cells expressing  only 18- 
kD bFGF cells (e, clone 43FGFHc8:1332.9 +  115.4/~m2). Cells 
transfected  with the vector alone (., Zipneo: mean track area  + 
SEM  =  666.4  -t- 42.5).  (b) Cells  expressing  WT bFGF and the 
dominant negative  FGF receptor (A, clone WTDNc2:491.4  + 
27.6 #m2;  +, WTDNc4:509.6 5:28.6/~m2), and cells expressing 
only WTbFGF (m, clone WT FGFHc5:1413 +  67.2/~m2). Cells 
transfected  with the vector alone (e, Zipneo: 666.4  +  42.5 #m2). 
43DNc31);  cells  transfected  with  18-kD  bFGF  cDNA  (e, 
43FGFHc3). Control cells (o, Zipneo). (b and d) Cells expressing 
HMW bFGF transfected with the dominant negative FGF receptor 
(-,  clone  365DNc5;  &,  365DNc63);  non-transfected  cells  (zx, 
365FGFHc3). Control cells (o, Zipneo). (a and b) 10% FCS; (c 
and d)  1% FCS.  The data presented  represent  the mean  +  SEM 
of duplicate  samples  and are representative  of three experiments. 
Discussion 
The data  reported  in this  paper  show that the  18-kD  and 
HMW forms of bFGF may mediate  certain cell  functions 
through separate mechanisms of action. This conclusion is 
based on the following observations: (a) Cells expressing 18- 
kD bFGF have high motility and surface-associated  18-kD 
bFGE  In contrast,  cells expressing  HMW bFGF have low 
motility and virtually no surface-associated bFGE (b) bFGF 
from 2.1 to 0.2% in cells expressing both 18-kD bFGF and 
the dominant negative bFGF receptor. The cloning efficiency 
for cells  expressing  WT bFGF was 2.8%.  This  value de- 
creased  to 0.87%  for cells  expressing WT bFGF plus the 
dominant negative bFGF receptor,  The cloning efficiencies 
of cells that expressed only HMW bFGF and that of cells ex- 
pressing both HMW bFGF and the dominant negative recep- 
tor were not significantly different (2 %).  With control Zip- 
neo cells, only a few colonies were detected (0.06%  cloning 
efficiency). 
These results  indicate  that  HMW bFGF,  but not  18-kD 
bFGF,  stimulates cell growth by a mechanism independent 
of its cell surface receptor. 
Table II.  Growth in Soft Agar 
Cells  Control  DN receptor transfected 
% -I- SEM 
18 kD  2.06 +  0.05  0.21  +  0.03 
WT bFGF  2.85  +  0.15  0.87  +  0.10 
HMW bFGF  2.04  5:0.22  2.03  +  0.26 
Cells expressing 18-kD bFGF, WT bFGF, or HMW bFGF transfected with the 
dominant negative bFGF receptor (18-kD bFGF: clone 43 DNcl 1 ; WT bFGF: 
clone WTDNc2; HMW bFGF: clone 365DNc2) or control ceils (18-kD bFGF: 
clone  43FGFHcI0;  WT  bFGF:  WTFGFHc3;  HMW  bFGF:  365FGFHc3) 
were plated at a density of 100,000 cells in 60 nun dishes in 2 ml of 0.3 % plat- 
ing agar on a 0.6% agar underlay. After three weeks, the number of colonies 
in each plate was counted. The data are expressed as a percent +  SEM of the 
total cells plated. 
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bFGF, but not in cells expressing HMW bFGE (c) Cells ex- 
pressing HMW bFGF have a reduced serum requirement for 
growth, whereas cells expressing  18-kD  bFGF proliferate 
poorly in low serum.  (d) Transfection of cells expressing 
HMW bFGF with 18-kD bFGF eDNA results in increased 
motility but has no effect on cell growth in low serum. (e) 
Expression of a dominant negative FGF receptor inhibits the 
migration and suppresses the growth in soft agar as well as 
the saturation density of cells expressing 18-kD bFGF, but 
has no effect on the growth of cells expressing HMW bFGE 
Measurement of the extracellular levels of 18  kD  and 
HMW bFGF revealed significantly more 18-kD bFGF than 
HMW bFGE We interpret these results to indicate that the 
extracellular release of 18-kD bFGF down-regulates recep- 
tors, increases motility, and stimulates growth via interac- 
tion with plasma membrane receptors. We propose that in 
the cells we have examined, HMW bFGF is not released in 
amounts sufficient to affect migration or bFGF receptor lev- 
els, but enhances growth by an intracellular mechanism. It 
important to note that the responses we have observed are 
probably dependent upon the absolute expression levels of 
each of the individual forms of  bFGF. As reported by Quarto 
et al. (1991b), transfection by the HMW bFGF eDNA we 
have used results in many clones of cells whose growth is in- 
hibited and in a few clones of cells whose growth is rapid. 
Among the transfected clones, those clones that grow rap- 
idly have multiple copies of integrated HMW bFGF cDNA, 
whereas the poorly growing cells usually have only one copy. 
The mechanism of growth inhibition induced by low levels 
of HMW bFGF expression is not understood at this time. 
Our studies have characterized those cells which grow rap- 
idly. No inhibition of cell growth was observed in cells ex- 
pressing low levels of 18-kD bFGF (Quarto et al.,  1991b). 
These cells grew in a manner similar to cells expressing high 
levels of 18-kD bFGE However,  the observation that even 
low expression of HMW bFGF results in impaired growth, 
whereas low expression of 18-kD bFGF does not, implies 
that HMW bFGF yields a phenotype different than that of 
18-kD bFGE 
The absolute level of expression of 18-kD bFGF may also 
be critical for the results we have observed. Contrary to our 
results, others have reported the growth in low or no serum 
of cells transformed by 18-kD bFGF (Sasada et al.,  1988; 
Neufeld et al., 1988). However, the eDNA used in those ex- 
periments began at or close to the AUG initiation codon 
specifying 18-kD bFGF and did not contain the 5' sequences 
required for HMW bFGF expression. Prats et al. (1992) have 
reported that these additional 5' sequences attenuate 18-kD 
bFGF translation. Therefore, the expression levels of 18-kD 
bFGF in the cells described by Sasada et al. (1988) and Neu- 
feld et al. (1988) were probably higher than those achieved 
by our cells. At these higher levels of expression, the serum 
requirement we observed might be masked. 
Cells expressing HMW bFGF are less motile than cells ex- 
pressing 18-kD bFGF. However,  exposure of these cells to 
exogenous HMW bFGF stimulates cell migration as effi- 
ciently as exposure to 18-kD bFGE This indicates that the 
low motility of cells expressing HMW bFGF is not because 
HMW bFGF lacks migration-stimulating activity. Rather, 
the poor motility and normal levels of receptor in cells ex- 
pressing HMW bFGF result from the extracellular concen- 
trations of  bFGF insufficient  to trigger receptor signaling. In 
addition, expression of a dominant negative FGF receptor 
reduces the motility of  cells expressing 18-kD bFGF, indicat- 
ing that increased cell migration requires the externalization 
of 18-kD  bFGF and  its interaction with cell  surface re- 
ceptors. 
Expression of a dominant negative FGF receptor affects 
neither the growth in 1% FCS nor the anchorage-dependent 
growth of cells producing HMW bFGE These data indicate 
that HMW bFGF can modulate cell proliferation by an intra- 
cellular mechanism independent of cell surface receptors. In 
the light of our present knowledge, the mechanism(s) by 
which intracellular HMW bFGF modulates cell prolifera- 
tion is not clear. A number of hypotheses can be considered. 
First, several data suggest that HMW bFGF can be translo- 
cated into the nucleus to exert its mitogenic activity as has 
been described for the Schwannoma-derived growth factor 
(Kimura, 1993).  The transport of exogenous 18-kD bFGF 
and aFGF to the nucleus, and their interaction with nuclear 
receptors or binding molecules have been described in sev- 
eral systems (Baldin et al., 1990;  Bouche et al.,  1987; Im- 
amura et al.,  1991; Zhan et al.,  1993;  Wiedlocha et al., 
1994). Other proteins and cytokines, including interleukin-1, 
are also translocated into the nucleus and may interact with 
nuclear receptors (Curtis et al., 1990; Weitzmann and Sav- 
age, 1992).  However,  a receptor for bFGF localized in the 
nuclear membrane and processed by the pathway used by the 
plasma  membrane  receptors  would  not  have  its  ligand- 
binding  domain  exposed  to  the  nucleoplasm.  Thus,  the 
mechanism by which HMW bFGF might interact with this 
receptor is not obvious. Other molecules involved in signal 
transduction,  including phosphoinositides and protein ki- 
nase C, are present in the nuclear membrane, suggesting the 
possibility of additional signaling systems in the nucleus 
(Divecha et al., 1991, 1993). Second, HMW bFGF may act 
as a transcription factor. This hypothesis is supported by the 
finding that 18-kD bFGF can modulate gene transcription in 
a cell-free system (Nakanishi et al., 1992), although the con- 
centrations at which bFGF exhibits this activity are high. 
Also, bFGF lacks a consensus sequence for a classical tran- 
scription  factor,  and it is,  therefore,  unlikely that HMW 
bFGF directly promotes gene transcription.  HMW bFGF 
might act indirectly by forming complexes with either tran- 
scription  factors  or  growth  suppressor  genes,  or  HMW 
bFGF may interfere with the activity of molecules involved 
in growth control, such as cyclins or phosphatases. Third, 
HMW bFGF may interact with a  cytoplasmic form of its 
membrane receptor. Overexpression of a cytoplasmic trun- 
cated form of type 1 FG  F receptor results in cell transforma- 
tion  (Yan et  al.,  1993).  Therefore,  soluble  cytoplasmic 
receptors may be functional, although the mechanism(s) by 
which these receptors transduce a signal is(are) unknown. 
The identification of proteins that specifically interact with 
HMW bFGF may help to elucidate the mechanism of trans- 
formation by HMW bFGF. 
In conclusion, our results  show that  18-kD  and HMW 
bFGF can have distinct mechanisms of action. The former 
modulates cell motility and proliferation through the interac- 
tion with its cell surface receptors.  The latter can act as a 
mitogen and an inducer of anchorage-independent growth 
through an intracellular mechanism of action but has essen- 
tially no effect on cell migration. Although additional roles 
The Journal of Cell Biology, Volume  129, 1995  242 for the different molecular weight forms of bFGF cannot be 
ruled out, these conclusions indicate a spatial and functional 
bipolarity in the action of bFGFs; the cell membranes as the 
site of action for 18-kD bFGF, and an intracellular,  perhaps 
nuclear,  site for HMW bFGE 
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